Cargando…

Effect of Moderate Aerobic Exercise on Complement Activation Pathways in Polycystic Ovary Syndrome Women

BACKGROUND: The complement system is pivotal in host defense mechanisms, protecting against pathogenic infection by regulating inflammation and cell immunity. Complement-related protein activation occurs through three distinct pathways: classical, alternative, and lectin-dependent pathways, which ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramanjaneya, Manjunath, Abdalhakam, Ibrahem, Bettahi, Ilham, Bensila, Milin, Jerobin, Jayakumar, Aye, Myint Myint, Alkasem, Meis, Sathyapalan, Thozhukat, Atkin, Stephen Lawrence, Abou-Samra, Abdul-Badi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892582/ https://www.ncbi.nlm.nih.gov/pubmed/35250845 http://dx.doi.org/10.3389/fendo.2021.740703

Ejemplares similares

Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women
por: Ramanjaneya, Manjunath, et al.
Publicado: (2020)

Regulation of circulating CTRP-2/CTRP-9 and GDF-8/GDF-15 by intralipids and insulin in healthy control and polycystic ovary syndrome women following chronic exercise training
por: Jerobin, Jayakumar, et al.
Publicado: (2021)

Insulin sensitivity variations in apparently healthy Arab male subjects: correlation with insulin and C peptide
por: Suleiman, Noor, et al.
Publicado: (2021)

MiRNA and associated inflammatory changes from baseline to hypoglycemia in type 2 diabetes
por: Ramanjaneya, Manjunath, et al.
Publicado: (2022)

Differences in protein expression, at the basal state and at 2 h of insulin infusion, in muscle biopsies from healthy Arab men with high or low insulin sensitivity measured by hyperinsulinemic euglycemic clamp
por: Bettahi, Ilham, et al.
Publicado: (2023)

Mitochondrial-Derived Peptides Are Down Regulated in Diabetes Subjects
por: Ramanjaneya, Manjunath, et al.
Publicado: (2019)

The metabolic footprint of compromised insulin sensitivity under fasting and hyperinsulinemic-euglycemic clamp conditions in an Arab population
por: Halama, Anna, et al.
Publicado: (2020)

Sputum and Plasma Neutrophil Elastase in Stable Adult Patients With Cystic Fibrosis in Relation to Chronic Pseudomonas Aeruginosa Colonization
por: AbdulWahab, Atqah, et al.
Publicado: (2021)

MicroRNA Changes Up to 24 h following Induced Hypoglycemia in Type 2 Diabetes
por: Ramanjaneya, Manjunath, et al.
Publicado: (2022)

Association of Complement-Related Proteins in Subjects With and Without Second Trimester Gestational Diabetes
por: Ramanjaneya, Manjunath, et al.
Publicado: (2021)

Corrigendum: Association of Complement-Related Proteins in Subjects With and Without Second Trimester Gestational Diabetes
por: Ramanjaneya, Manjunath, et al.
Publicado: (2021)

Circulating microRNA signatures in patients with chronic Urticaria
por: Jerobin, Jayakumar, et al.
Publicado: (2023)

Circulatory EVs as a predictor of chronic urticarial activity
por: Mohammed-Ali, Ramzy, et al.
Publicado: (2022)

High Endurance Elite Athletes Show Age-dependent Lower Levels of Circulating Complements Compared to Low/Moderate Endurance Elite Athletes
por: Al-Muraikhy, Shamma, et al.
Publicado: (2021)

Dysregulated Metabolic Pathways in Subjects with Obesity and Metabolic Syndrome
por: Mir, Fayaz Ahmad, et al.
Publicado: (2022)

Characteristic MicroRNAs Linked to Dysregulated Metabolic Pathways in Qatari Adult Subjects With Obesity and Metabolic Syndrome
por: Mir, Fayaz Ahmad, et al.
Publicado: (2022)

An integrated multi-omic approach demonstrates distinct molecular signatures between human obesity with and without metabolic complications: a case–control study
por: Mir, Fayaz Ahmad, et al.
Publicado: (2023)

apoA2 correlates to gestational age with decreased apolipoproteins A2, C1, C3 and E in gestational diabetes
por: Ramanjaneya, Manjunath, et al.
Publicado: (2021)

ODP141 Complement Activation and Homeostasis Works Primarily Through the Alternative Pathway in Polycystic Ovary Syndrome
por: Atkin, Stephen, et al.
Publicado: (2022)

Components of the Complement Cascade Differ in Polycystic Ovary Syndrome
por: Butler, Alexandra E., et al.
Publicado: (2022)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
por: Sathyapalan, Thozhukat, et al.
Publicado: (2010)

Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients
por: Butler, Alexandra E., et al.
Publicado: (2023)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Metabolomic Profiling of Pregnancies With Polycystic Ovary Syndrome Identifies a Unique Metabolic Signature and Potential Predictive Biomarkers of Low Birth Weight
por: Diboun, Ilhame, et al.
Publicado: (2021)

Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
por: Alalami, Huda, et al.
Publicado: (2018)

Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus—a study protocol
por: Suleiman, Noor, et al.
Publicado: (2022)

A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2020)

Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D
por: Moin, Abu Saleh Md, et al.
Publicado: (2022)

The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2021)

The Association of the Polychlorinated Biphenyl Class of Endocrine Disruptors With Polycystic Ovary Syndrome and Thyroid Dysfunction
por: Brennan, Edwina, et al.
Publicado: (2021)

COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Acute Hypertriglyceridemia Induces Platelet Hyperactivity That is Not Attenuated by Insulin in Polycystic Ovary Syndrome
por: Aye, Myint Myint, et al.
Publicado: (2014)

Oxidative Stress Markers and Heat Shock Proteins in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D
por: Nandakumar, Manjula, et al.
Publicado: (2023)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Vitamin D association with coagulation factors in polycystic ovary syndrome is dependent upon body mass index
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

iPSCs derived from insulin resistant offspring of type 2 diabetic patients show increased oxidative stress and lactate secretion
por: Memon, Bushra, et al.
Publicado: (2022)

Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ihrkirp29q1f6ijinimnde910c